维生素 D 与 COVID-19:近期证据概述。
Vitamin D and COVID-19: An Overview of Recent Evidence.
机构信息
Monash Centre for Health Research and Implementation (MCHRI), Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3168, Australia.
出版信息
Int J Mol Sci. 2021 Sep 29;22(19):10559. doi: 10.3390/ijms221910559.
The novel coronavirus severe acute respiratory syndrome () has progressed rapidly from an outbreak to a global pandemic, with new variants rapidly emerging. Coronavirus disease 2019 (COVID-19), the disease resulting from infection, can lead to multiorgan damage. Due to the extremely contagious and fatal nature of the virus, it has been a priority of medical research to find effective means of treatment. Amid this search, the role of vitamin D in modulating various aspects of the innate and adaptive immune system has been discussed. This review aims to consolidate the research surrounding the role of vitamin D in the treatment and prevention of COVID-19. While there are some conflicting results reported, the consensus is that vitamin D has a host of immunomodulatory effects which may be beneficial in the context of COVID-19 and that low levels of vitamin D can result in dysfunction of crucial antimicrobial effects, potentially contributing to poor prognosis. Studies also show that the effects of low vitamin D can be mitigated via supplementation, although the benefits of vitamin D supplementation in the treatment of COVID-19 remain controversial.
新型冠状病毒严重急性呼吸综合征(SARS-CoV-2)迅速从局部爆发演变为全球大流行,新的变异株不断出现。由 感染引起的 2019 年冠状病毒病(COVID-19)可导致多器官损伤。由于该病毒具有极强的传染性和致命性,因此寻找有效的治疗方法一直是医学研究的重点。在这一探索过程中,维生素 D 在调节先天和适应性免疫系统的各个方面的作用受到了讨论。本综述旨在整合围绕维生素 D 在 COVID-19 治疗和预防中的作用的研究。尽管有一些相互矛盾的结果报告,但共识是维生素 D 具有多种免疫调节作用,在 COVID-19 背景下可能有益,而维生素 D 水平低会导致关键抗菌作用的功能障碍,可能导致预后不良。研究还表明,通过补充可以减轻低维生素 D 的影响,尽管维生素 D 补充在 COVID-19 治疗中的益处仍存在争议。